A general integrative genomic feature transcription factor binding site prediction method applied to analysis of USF1 binding in cardiovascular disease.
Transcription factors are key mediators of human complex disease processes. Identifying the target genes of transcription factors will increase our understanding of the biological network leading to disease risk. The prediction of transcription factor binding sites (TFBSs) is one method to identify these target genes; however, current prediction methods need improvement. We chose the transcription factor upstream stimulatory factor 1 ( USF1 ) to evaluate the performance of our novel TFBS prediction method because of its known genetic association with coronary artery disease (CAD) and the recent availability of USF1 chromatin immunoprecipitation microarray (ChIP-chip) results. The specific goals of our study were to develop a novel and accurate genome-scale method for predicting USF1 binding sites and associated target genes to aid in the study of CAD. Previously published USF1 ChIP-chip data for 1 per cent of the genome were used to develop and evaluate several kernel logistic regression prediction models. A combination of genomic features (phylogenetic conservation, regulatory potential, presence of a CpG island and DNaseI hypersensitivity), as well as position weight matrix (PWM) scores, were used as variables for these models. Our most accurate predictor achieved an area under the receiver operator characteristic curve of 0.827 during cross-validation experiments, significantly outperforming standard PWM-based prediction methods. When applied to the whole human genome, we predicted 24,010 USF1 binding sites within 5 kilobases upstream of the transcription start site of 9,721 genes. These predictions included 16 of 20 genes with strong evidence of USF1 regulation. Finally, in the spirit of genomic convergence, we integrated independent experimental CAD data with these USF1 binding site prediction results to develop a prioritised set of candidate genes for future CAD studies. We have shown that our novel prediction method, which employs genomic features related to the presence of regulatory elements, enables more accurate and efficient prediction of USF1 binding sites. This method can be extended to other transcription factors identified in human disease studies to help further our understanding of the biology of complex disease.
Wang
Tianyuan
T
Department of Medicine and Center for Human Genetics, Duke University Medical Center, Durham, NC 27710, USA.
Furey
Terrence S
TS
Connelly
Jessica J
JJ
Ji
Shihao
S
Nelson
Sarah
S
Heber
Steffen
S
Gregory
Simon G
SG
Hauser
Elizabeth R
ER
D000818:Animals; D001665:Binding Sites; D002318:Cardiovascular Diseases / Q000378:metabolism*; D047369:Chromatin Immunoprecipitation; D023281:Genomics / Q000379:methods*; D006801:Humans; D012044:Regression Analysis; D014157:Transcription Factors / Q000378:metabolism; D051720:Upstream Stimulatory Factors / Q000378:metabolism*
D014157:Transcription Factors; C497181:USF1 protein, human; D051720:Upstream Stimulatory Factors